Edwards Lifesciences Corporation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Edwards Lifesciences Corporation (EW) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $2.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2026-02-25
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-12-31 was $0.00.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2018-12-31 was $0.00.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2018-09-30 was $0.00.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2018-06-30 was $50.00M.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2025 was $2.00M.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Edwards Lifesciences Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2018 was $60.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.00M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-05 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-02-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $0.00 derived: sum of 2 quarters · filed 2020-02-14 | $50.00M derived: sum of 3 quarters · filed 2020-02-14 | $60.00M 10-K · filed 2020-02-14 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $50.00M derived: sum of 2 quarters · filed 2018-10-26 | $60.00M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $60.00M 10-Q · filed 2018-07-27 | ||
| 2018-03-31 | $10.00M 10-Q · filed 2018-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |